Jurors found that British celebrity chef Mark Sargeant sexually assaulted Kimberly Goesling in a hotel room in Germany in 2018, but rejected her claim that American Airlines is to blame.
Dallas Company’s Patent-Infringement Suit Against Twitter Moving Toward Trial
U.S. District Judge David C. Godbey, reversing a decision he made in 2016, refuses to dismiss the suit over what the plaintiff, VidStream, says is at least $600 million in unpaid patent royalties.
AZA Team Slaps Down ‘Frivolous’ Anti-SLAPP Appeal
Calling the appeal of a construction dispute “a poster child” for abuse of the interlocutory appellate process, the 14th Court of Appeals sent the case back to a Houston district court for trial.
Feds Are 11 for 11 in Guilty Pleas in $300M Medical-Lab Kickback Scheme
Less than three months after their indictment, 11 Texans, including two doctors, have pleaded guilty in a payoff scheme involving needless lab tests billed to Medicare and other federal programs by three Dallas-area labs.
Dialysis Giant Acquitted in Federal Criminal Case Over Non-Poaching Agreements
Tom Melsheimer, who represented DaVita Inc.’s former CEO at the trial in Denver, said his client’s conduct may have been ‘obnoxious,’ but it wasn’t a crime. The jury agreed.
Burns Charest Scores Victory in Fight Over Vast Costa Rican Energy Concession
The Dallas law firm represented GT Resources of Denver, which won a $41 million verdict this week in a dispute over royalties on 2.3 million acres in Costa Rica.
Sherman Jury Rejects Feds’ Criminal Wage-Fixing Claim in Home-Health Case
In a groundbreaking criminal case, the former owner of a staffing agency that provided physical therapists to home-healthcare companies is convicted of obstructing an FTC investigation – but acquitted of conspiring with competitors to fix wages.
East Texas Jury Awards $41.8 Million in Cancer-Drug Patent Case
A Seattle company represented by Johnny Ward of Ward, Smith & Hill prevails in a suit claiming patent infringement by a Japanese big pharma firm that reaped hundreds of millions of dollars from sales of an innovative breast-cancer treatment.
A&M Law Is Working Hard at Ranking Higher, and Showing Success
The Texas A&M University School of Law intends to become one of America’s greatest law schools. That’s not just A&M Chancellor John Sharp’s lofty goal or an empty objective for the law school dean. But in the so-important U.S. News rankings the school has been on a meteoric rise since A&M bought it almost 10 years ago. “The top 10 is where we ought to be,” Sharp says.
‘We’re Not Stupid,’ SEC’s Regional Director Warns Companies Hoping to Hide Irregularities
Panelists discussed key developments and enforcement trends in rapidly evolving areas of securities regulation including cryptocurrency trading and special purpose acquisition companies (SPACs) and environmental, social and governance disclosures related to climate change.